Comparable studies using the same IHC scoring criteria showed a HER-2 positivity of 17% in adenocarcinomas of the esophagus and of 27% in resection specimens of patients with cUICC-II/-III rectal cancer [21][23]. This evidence concerns the gene ERBB2 and adenocarcinoma.